首页> 外文期刊>Vaccine >Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
【24h】

Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.

机译:HSP-70,KMP-11和PFR-2利什曼病抗原在犬内脏利什曼病实验模型中的免疫原性。

获取原文
获取原文并翻译 | 示例
           

摘要

Zoonotic visceral leishmaniasis (ZVL) is a parasitic disease caused by Leishmania infantum/L. chagasi that is emerging as an important medical and veterinary problem. Dogs are the domestic reservoir for this parasite and, therefore, the main target for controlling the transmission to humans. In the present work, we have evaluated the immunogenicity of the Leishmania infantum heat shock protein (HSP)-70, paraflagellar rod protein (PFR)-2 and kinetoplastida membrane protein (KMP)-11 recombinant proteins in dogs experimentally infected with the parasite. We have shown that peripheral blood mononuclear cells (PBMC) from experimentally infected dogs proliferated in response to these recombinant antigens and against the soluble leishmanial antigen (SLA). We have also quantified the mRNA expression level of the cytokines induced in PBMC upon stimulation with the HSP-70, PFR-2 and KMP-11 proteins. These recombinant proteins induced an up-regulation of IFN-gamma. HSP-70 and PFR-2 also produced an increase of the TNF-alpha transcripts abundance. No measurable induction of IL-10 was observed and low levels of IL-4 mRNA were produced in response to the three mentioned recombinant antigens. Serum levels of specific antibodies against HSP-70, PFR-2 and KMP-11 recombinant proteins were also determined in these animals. Our study showed that HSP-70, KMP-11 and PFR-2 proteins are recognized by infected canines. Furthermore, these antigens produce a Th1-type immune response, suggesting that they may be involved in protection. The identification as vaccine candidates of Leishmania antigens that elicit appropriate immune responses in the canine model is a key step in the rational approach to generate a vaccine for canine visceral leishmaniasis.
机译:人畜共患性内脏利什曼病(ZVL)是由婴儿利什曼原虫/ L引起的寄生虫病。恰加斯(chagasi)成为一个重要的医学和兽医问题。狗是这种寄生虫的家养动物,因此是控制向人类传播的主要目标。在本工作中,我们已经评估了利什曼原虫婴儿热休克蛋白(HSP)-70,鞭毛杆蛋白(PFR)-2和动塑料膜蛋白(KMP)-11重组蛋白在被寄生虫感染的狗中的免疫原性。我们已经表明,来自实验感染狗的外周血单核细胞(PBMC)响应这些重组抗原和可溶性利什曼原虫抗原(SLA)而增殖。我们还量化了HSP-70,PFR-2和KMP-11蛋白刺激后,PBMC中诱导的细胞因子的mRNA表达水平。这些重组蛋白诱导了IFN-γ的上调。 HSP-70和PFR-2也增加了TNF-alpha转录物的丰度。没有观察到可测量的IL-10诱导,并且响应于上述三种重组抗原产生低水平的IL-4 mRNA。在这些动物中还测定了针对HSP-70,PFR-2和KMP-11重组蛋白的特异性抗体的血清水平。我们的研究表明,HSP-70,KMP-11和PFR-2蛋白可被感染的犬识别。此外,这些抗原产生Th1型免疫反应,表明它们可能参与保护。在犬模型中鉴定出引发适当免疫反应的利什曼原虫抗原的候选疫苗,是产生犬内脏利什曼病疫苗的合理方法中的关键步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号